| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3906 |
| Trial ID | NCT06462248 |
| Disease | Non-Hodgkin's Lymphoma | Lymphocytic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CUCART19 |
| Phase | Phase2 |
| Recruitment status | Recruiting |
| Title | A Single Arm, Open-labelled Phase II Clinical Trial of Anti-CD19 Chimeric Antigen Receptor Modified T-cell (CAR-T) for Treatment of B-cell Haematological Malignancies |
| Year | 2024 |
| Country | China |
| Company sponsor | Chi Kong Li |
| Other ID(s) | CU2022 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||
|
|||||||